Free Trial

Sanara MedTech (SMTI) News Today

$29.70
-0.49 (-1.62%)
(As of 05/31/2024 ET)
FY2024 Earnings Estimate for Sanara MedTech Inc. (NASDAQ:SMTI) Issued By Cantor Fitzgerald
Sanara MedTech Inc. (NASDAQ:SMTI - Free Report) - Research analysts at Cantor Fitzgerald dropped their FY2024 EPS estimates for Sanara MedTech in a research report issued on Wednesday, May 15th. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will post earnings per share of ($0
Sanara MedTech (NASDAQ:SMTI) Earns "Overweight" Rating from Cantor Fitzgerald
Cantor Fitzgerald restated an "overweight" rating and issued a $44.00 price objective on shares of Sanara MedTech in a report on Wednesday.
Sanara MedTech (SMTI) to Release Quarterly Earnings on Monday
Sanara MedTech (NASDAQ:SMTI) will be releasing earnings after the market closes on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=417995)
Sanara MedTech (NASDAQ:SMTI) Shares Down 0.2%
Sanara MedTech (NASDAQ:SMTI) Stock Price Down 0.2%
Sanara Medtech Inc (SMTI)
Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00
Cantor Fitzgerald decreased their price target on shares of Sanara MedTech from $49.00 to $44.00 and set an "overweight" rating for the company in a report on Wednesday.
Sanara MedTech's Earnings: A Preview
Sanara MedTech (SMTI) Set to Announce Earnings on Monday
Sanara MedTech (NASDAQ:SMTI) will be releasing earnings after the market closes on Monday, March 25, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=573497)
CGI Cellerate RX, LLC's Net Worth
Short Interest in Sanara MedTech Inc. (NASDAQ:SMTI) Decreases By 16.2%
Sanara MedTech Inc. (NASDAQ:SMTI - Get Free Report) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 119,200 shares, a decline of 16.2% from the December 31st total of 142,200 shares. Based on an average daily volume of 13,600 shares, the short-interest ratio is currently 8.8 days. Approximately 3.5% of the shares of the company are sold short.
Sanara MedTech Inks Exclusive License Agreement With Tufts University
Sanara MedTech Inc. Announces Third Quarter 2023 Results
Sanara MedTech Inc SMTI
Sanara MedTech to Participate in Two Upcoming Conferences
Get Sanara MedTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter.

The only financial event in 2024 that matters (Ad)

Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.

Stream the documentary for free by clicking here

SMTI Media Mentions By Week

SMTI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SMTI
News Sentiment

1.89

0.76

Average
Medical
News Sentiment

SMTI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SMTI Articles
This Week

1

1

SMTI Articles
Average Week

Get Sanara MedTech News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SMTI) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners